Home › Hopkins and Bayer to develop treatments for eye diseases
 

Keywords :   


Hopkins and Bayer to develop treatments for eye diseases

2015-06-16 14:58:01| Chemicals - Topix.net

The Johns Hopkins University has entered into a five-year agreement with Bayer HealthCare to develop drugs to treat diseases of the eye. Under the agreement, researchers at the Wilmer Eye Institute at Johns Hopkins and Bayer will work together to study things such as biomarkers for back-of-the-eye diseases with few available treatments.

Tags: develop eye diseases treatments

Category:Chemicals

Latest from this category

All news
07.05Trust in Paint Brand and Retailer Now Major Indicator of Customer Satisfaction, J.D. Power Finds
07.05Interpon Launches Structura Powder Coating Collection in North America
07.05Visitor Registration Open for Coatings for Africa
07.05OQ Chemicals Resumes Operations in German Plants
07.05Polychem Powder Coatings Moves into New Production Facility
06.05Axalta Building Products Launches Zenamel Wood Coatings for Cabinets
06.05Syensqo CEO, Ilham Kadri Becomes Cefic President
06.05Hempel Announces Intent to Divest J.W. Ostendorf and Renaulac
Chemicals »
08.05E-gate outage lessons 'must be learnt'
08.05Allerson named 2024 Allen D. Leman Science in Practice Award winner
08.05Pirbright, The Vaccine Group partner on African swine fever vaccine
08.05Global pork industry optimistic as feed costs fall, demand stabilizes
08.05Brewdog boss James Watt steps down from CEO role
08.05US revokes licences for sales of chips to Huawei
08.05Prime Packaging invests in Nilpeter FA-26 flexo press
08.05MCC Drogheda honored at Irish Print Awards
More »